Drug · DIN 02337819
EXTAVIA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 8, 2022; first marketed May 5, 2010.
- Drug Identification Number (DIN)
- 02337819
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Interferon beta-1b L03AB08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INTERFERON BETA-1B | 0.3 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 27, 2009: NOC 10812New Drug Submission (NDS) · New product name and new manufacturer's name